Cargando…

Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic

Background: Central-line–associated bloodstream infections (CLABSIs) are an important public health issue. Recent data from the CDC have shown an increase in healthcare-associated infections (including CLABSI) during the COVID-19 pandemic. Therefore, the main aim of this project was to analyze the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Satta, Giovanni, Smith, Kristin, Smith, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594238/
http://dx.doi.org/10.1017/ash.2023.285
_version_ 1785124603766505472
author Satta, Giovanni
Smith, Kristin
Smith, Jacob
author_facet Satta, Giovanni
Smith, Kristin
Smith, Jacob
author_sort Satta, Giovanni
collection PubMed
description Background: Central-line–associated bloodstream infections (CLABSIs) are an important public health issue. Recent data from the CDC have shown an increase in healthcare-associated infections (including CLABSI) during the COVID-19 pandemic. Therefore, the main aim of this project was to analyze the epidemiology of central-line–associated bloodstream infection during different periods at the Baystate Medical Center (Springfield, MA) before, during, and after COVID-19 peaks of infection. Methods: Two specific periods were considered during the year (quarter January–March and quarter July–September) to consider potential seasonal variations, and the incidence of CLABSI during those 2 quarters was analyzed for 4 different years: 2019 (prepandemic), 2020–2021 (intrapandemic), and 2022 (postpandemic). An analysis of the microbial pathogens causing line infections was also performed to investigate differences described by other authors. Results: In total, 97 CLABSI (all from different patients) were reported into the NHSN website during the 8 periods considered. The average age of the patients was 55 years, with a male:female ratio of 57%:43%, and 14 renal patients were on dialysis. The CLABSI rates ranged from a minimum of 1.11 in Q1 of 2020 (start of COVID) to a maximum of 2 in Q3 of 2021 (SARS-CoV-2 delta variant) (Table 1). A statistical comparison of the pre–COVID-19 period with the respective quarters during the pandemic years (2020, 2021, and 2022) did not show any significant differences (Table 2). In term of microbiological data, of the 97 patients with CLABSIs, most of the patients (n = 70) had only 1 pathogen isolated, 14 patients had 2 pathogens, and 3 patients had 3 pathogens, bringing the total number of bacteria cultured to 117. Candida spp and Enterococcus spp were the most frequently isolated pathogens at 19% and 13%, respectively (Fig. 1). There was no statistically significant difference between the pre–COVID-19 and intra–COVID-19 periods for Candida spp (rate ratio, 1.391; 95% CI, 0.5477–3.533; P = .48) or Enterococcus spp (rate ratio, 2.385; 95% CI, 0.8365–6.798; P = .09). Conclusions: The COVID-19 pandemic did not seem to have an impact on the local epidemiology at Baystate Medical Center in terms of CLABSI rates or type of pathogens causing infections, but the sample size taken into consideration may not have been powerful enough to detect statistical significance. Note. This project was carried out as part of Dr Satta’s MPH requirements at UMass. Disclosures: None
format Online
Article
Text
id pubmed-10594238
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105942382023-10-25 Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic Satta, Giovanni Smith, Kristin Smith, Jacob Antimicrob Steward Healthc Epidemiol Clabsi Background: Central-line–associated bloodstream infections (CLABSIs) are an important public health issue. Recent data from the CDC have shown an increase in healthcare-associated infections (including CLABSI) during the COVID-19 pandemic. Therefore, the main aim of this project was to analyze the epidemiology of central-line–associated bloodstream infection during different periods at the Baystate Medical Center (Springfield, MA) before, during, and after COVID-19 peaks of infection. Methods: Two specific periods were considered during the year (quarter January–March and quarter July–September) to consider potential seasonal variations, and the incidence of CLABSI during those 2 quarters was analyzed for 4 different years: 2019 (prepandemic), 2020–2021 (intrapandemic), and 2022 (postpandemic). An analysis of the microbial pathogens causing line infections was also performed to investigate differences described by other authors. Results: In total, 97 CLABSI (all from different patients) were reported into the NHSN website during the 8 periods considered. The average age of the patients was 55 years, with a male:female ratio of 57%:43%, and 14 renal patients were on dialysis. The CLABSI rates ranged from a minimum of 1.11 in Q1 of 2020 (start of COVID) to a maximum of 2 in Q3 of 2021 (SARS-CoV-2 delta variant) (Table 1). A statistical comparison of the pre–COVID-19 period with the respective quarters during the pandemic years (2020, 2021, and 2022) did not show any significant differences (Table 2). In term of microbiological data, of the 97 patients with CLABSIs, most of the patients (n = 70) had only 1 pathogen isolated, 14 patients had 2 pathogens, and 3 patients had 3 pathogens, bringing the total number of bacteria cultured to 117. Candida spp and Enterococcus spp were the most frequently isolated pathogens at 19% and 13%, respectively (Fig. 1). There was no statistically significant difference between the pre–COVID-19 and intra–COVID-19 periods for Candida spp (rate ratio, 1.391; 95% CI, 0.5477–3.533; P = .48) or Enterococcus spp (rate ratio, 2.385; 95% CI, 0.8365–6.798; P = .09). Conclusions: The COVID-19 pandemic did not seem to have an impact on the local epidemiology at Baystate Medical Center in terms of CLABSI rates or type of pathogens causing infections, but the sample size taken into consideration may not have been powerful enough to detect statistical significance. Note. This project was carried out as part of Dr Satta’s MPH requirements at UMass. Disclosures: None Cambridge University Press 2023-09-29 /pmc/articles/PMC10594238/ http://dx.doi.org/10.1017/ash.2023.285 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clabsi
Satta, Giovanni
Smith, Kristin
Smith, Jacob
Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title_full Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title_fullStr Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title_full_unstemmed Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title_short Retrospective data analysis of CLABSI rates at Baystate Medical Center during the COVID-19 pandemic
title_sort retrospective data analysis of clabsi rates at baystate medical center during the covid-19 pandemic
topic Clabsi
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594238/
http://dx.doi.org/10.1017/ash.2023.285
work_keys_str_mv AT sattagiovanni retrospectivedataanalysisofclabsiratesatbaystatemedicalcenterduringthecovid19pandemic
AT smithkristin retrospectivedataanalysisofclabsiratesatbaystatemedicalcenterduringthecovid19pandemic
AT smithjacob retrospectivedataanalysisofclabsiratesatbaystatemedicalcenterduringthecovid19pandemic